Literature DB >> 19765730

Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.

Bin Xie1, Renxin Xing, Ping Chen, Yuanbin Gou, Shan Li, Jing Xiao, Jiahong Dong.   

Abstract

BACKGROUND: Cell migration is a basis for invasion and metastasis of malignant tumors. Receptor tyrosine kinases are recognized as important therapeutic targets in antineoplastic strategies. C-met is a receptor tyrosine kinase highly expressed in human hepatocellular carcinoma (HCC) cell line MHCC97-H. Higher expression of c-met in tumor tissue can lead to scattering, angiogenesis, proliferation, enhanced cell motility, invasion, and eventually, metastasis. To explore the roles of c-met in modulating the motility of cell, we silenced c-met expression in the HCC line MHCC97-H by RNA interference (RNAi).
MATERIALS AND METHODS: For transient expression, c-met-siRNA 1,2 recombinant plasmids were transfected into phoenix A cells. The MHCC97-H cells were cultured in Dulbecco's modified Eagles's medium (DMEM) with 10% fetal bovine serum (FBS) to establish MHCC97-H HCC cells stably expressing c-met-siRNA. MHCC97-H cells were treated with the recombinant virus for assay of c-met mRNA and protein, evaluation of growth and invasion of MHCC97-H cells, and identification of hepatitis B virus X (HBX) protein correlation with c-met.
RESULTS: After transfection of c-met-siRNA for 48 h, the expression of c-met decreased markedly in MHCC97-H cells; the most effective site of the siRNA target sequence is at the 537 upstream, far from the transcription start. In addition, the proliferation, motility, and invasive ability of MHCC97-H cells were significantly inhibited. Furthermore, we showed that hepatitis B virus (HBV) X protein (HBX) potentiated the activities of the extracellular signal-regulated kinase 1/2 (ERK1/2) in MHCC97-H cells. Treatment with extracellular signal-regulated kinase (ERK) inhibitor (U0126), but not P38 MAPK inhibitor (SB203580) or phosphatidylinositol 3-kinase (PI3K) inhibitor (wortmannin), markedly suppressed the expression of c-met protein in MHCC97-H cells.
CONCLUSION: These results indicate that the over-expression of c-met protein plays an important role in the cell invasion of MHCC97-H, and HBX protein may promote the expression of c-met by ERKs pathway. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765730     DOI: 10.1016/j.jss.2009.04.030

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

1.  Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines.

Authors:  T-H Hung; Y-H Li; C-P Tseng; Y-W Lan; S-C Hsu; Y-H Chen; T-T Huang; H-C Lai; C-M Chen; K-B Choo; K-Y Chong
Journal:  Cancer Gene Ther       Date:  2015-04-24       Impact factor: 5.987

2.  Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells.

Authors:  Yuncheng Li; Sulin Zhang; Zhengang Tang; Jian Chen; Weijia Kong
Journal:  Tumour Biol       Date:  2011-09-16

3.  Hepatic Thermal Ablation: Effect of Device and Heating Parameters on Local Tissue Reactions and Distant Tumor Growth.

Authors:  Erik Velez; S Nahum Goldberg; Gaurav Kumar; Yuanguo Wang; Svetlana Gourevitch; Jacob Sosna; Tyler Moon; Christopher L Brace; Muneeb Ahmed
Journal:  Radiology       Date:  2016-07-13       Impact factor: 11.105

Review 4.  Targeting the HGF/c-MET pathway in hepatocellular carcinoma.

Authors:  Lipika Goyal; Mandar D Muzumdar; Andrew X Zhu
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

5.  Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition.

Authors:  Muneeb Ahmed; Gaurav Kumar; Marwan Moussa; Yuanguo Wang; Nir Rozenblum; Eithan Galun; S Nahum Goldberg
Journal:  Radiology       Date:  2015-09-29       Impact factor: 11.105

Review 6.  Human viral oncogenesis: a cancer hallmarks analysis.

Authors:  Enrique A Mesri; Mark A Feitelson; Karl Munger
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

7.  The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models.

Authors:  Friedhelm Bladt; Manja Friese-Hamim; Christian Ihling; Claudia Wilm; Andree Blaukat
Journal:  Cancers (Basel)       Date:  2014-08-19       Impact factor: 6.639

Review 8.  The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.

Authors:  Chi-Tan Hu; Jia-Ru Wu; Chuan-Chu Cheng; Wen-Sheng Wu
Journal:  Cancers (Basel)       Date:  2017-05-26       Impact factor: 6.639

9.  A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis.

Authors:  A Santoro; M Simonelli; C Rodriguez-Lope; P Zucali; L H Camacho; A Granito; N Senzer; L Rimassa; G Abbadessa; B Schwartz; M Lamar; R E Savage; J Bruix
Journal:  Br J Cancer       Date:  2013-01-03       Impact factor: 7.640

Review 10.  c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.

Authors:  Alessandro Granito; Elena Guidetti; Laura Gramantieri
Journal:  J Hepatocell Carcinoma       Date:  2015-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.